Longitudinal Study of Plasma Metabolites During Menopause and Their Associations With Later Onset of Metabolic Syndrome - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Long-Term Analysis of Plasma Metabolite Changes During Menopause and Their Links to Subsequent Development of Metabolic Syndrome

  • By

  • Atsuko Miyake

  • Miho Iida

  • Sei Harada

  • Daisuke Sugiyama

  • Minako Matsumoto

  • Naoko Miyagawa

  • Ryota Toki

  • Shun Edagawa

  • Aya Hirata

  • Kazuyo Kuwabara

  • Tomonori Okamura

  • Asako Sato

  • Kaori Amano

  • Akiyoshi Hirayama

  • Masahiro Sugimoto

  • Tomoyoshi Soga

  • Masaru Tomita

  • Kazuharu Arakawa

  • Iori Kisu

  • Wataru Yamagami

  • Toru Takebayashi

  • December 13, 2025

Share

  • 1

    This study analyzed plasma metabolite changes during menopause and their links to metabolic syndrome (MetS) over a mean follow-up of 5 years.

  • 2

    Eighteen metabolites, particularly related to branched-chain amino acids and homocysteine metabolism, changed significantly during menopause.

  • 3

    Of the 695 women without MetS at baseline, 9.4% developed MetS, with glutamate levels significantly associated with higher MetS risk.

  • 4

    Higher levels of glutamate, valine, leucine, and cystine were linked to the development of hyperglycemia in postmenopausal women.

  • 5

    The findings emphasize the importance of monitoring specific metabolites to understand metabolic alterations and risks associated with menopause.

Original Source(s)

Related Content